Diabetes: how to manage chronic kidney disease (vol 11, 2021-9-10, 2022)

被引：0
|
作者：
Clements, J. N.
机构：
来源：
DRUGS IN CONTEXT | 2022年 / 11卷
关键词：
D O I：
10.7573/dic.2022-6-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes (vol 15, pg 501, 2022)
    Lerma, E. V.
    Wilson, D. J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (11) : I - I
  • [22] Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure (vol 9, 807, 2022)
    McMurray, J. J., V
    Wheeler, D. C.
    Stefansson, B., V
    Jongs, N.
    Postmus, D.
    Correa-Rotter, R.
    Chertow, G. M.
    Hou, F. F.
    Rossing, P.
    Sjostrom, C. D.
    Solomon, S. D.
    Toto, R. D.
    Langkilde, A. M.
    Heerspink, H. J. L.
    JACC-HEART FAILURE, 2022, 10 (06) : 446 - 447
  • [23] Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (vol 81, pg 1467, 2021)
    Valdivielso, Jose M.
    Balafa, Olga
    Ekart, Robert
    Ferro, Charles J.
    Mallamaci, Francesca
    Mark, Patrick B.
    Rossignol, Patrick
    Sarafidis, Pantelis
    Del Vecchio, Lucia
    Ortiz, Alberto
    DRUGS, 2021, 81 (15) : 1819 - 1819
  • [24] Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial (vol 9, pg 743, 2021)
    Heerspink, H. J. L.
    Jongs, N.
    Chertow, G. M.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (10): : E10 - E10
  • [25] Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update
    Navaneethan, Sankar D.
    Zoungas, Sophia
    Caramori, M. Luiza
    Chan, Juliana C. N.
    Heerspink, Hiddo J. L.
    Hurst, Clint
    Liew, Adrian
    Michos, Erin D.
    Olowu, Wasiu A.
    Sadusky, Tami
    Tandon, Nikhil
    Tuttle, Katherine R.
    Wanner, Christoph
    Wilkens, Katy G.
    Craig, Jonathan C.
    Tunnicliffe, David J.
    Tonelli, Marcello
    Cheung, Michael
    Earley, Amy
    Rossing, Peter
    de Boer, Ian H.
    Khunti, Kamlesh
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (03) : 381 - 387
  • [26] Aldosterone in chronic kidney disease and renal outcomes (vol 43, ehac352, 2022)
    Verma, Ashish
    Vaidya, Anand
    Subudhi, Sonu
    Waikar, Sushrut S.
    EUROPEAN HEART JOURNAL, 2022, 43 (46) : 4814 - 4814
  • [27] Nutritional Management for Dogs and Cats with Chronic Kidney Disease (vol 51, pg 685, 2021)
    Parker, Valerie J.
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2021, 51 (05) : IX - IX
  • [28] Screening of Fabry disease in patients with chronic kidney disease in Japan (vol 36, gfaa324, 2021)
    Nagata, Akiko
    Nasu, Makoto
    Kaida, Yusuke
    Nakayama, Yosuke
    Kurokawa, Yuka
    Nakamura, Nao
    Shibata, Ryo
    Hazama, Takuma
    Tsukimura, Takahiro
    Togawa, Tadayasu
    Saito, Seiji
    Sakuraba, Hitoshi
    Fukami, Kei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (11) : 2155 - 2159
  • [29] EPIDEMIOLOGY OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH DIABETES IN RUSSIAN FEDERATION ACCORDING TO THE FEDERAL DIABETES REGISTER 2010-2022
    Shamkhalova, Minara S.
    Vikulova, Olga K.
    Zheleznyakova, Anna V.
    Isakov, Mikhail A.
    Shestakova, Marina V.
    Dedov, Ivan I.
    Mokrysheva, Natalya G.
    DIABETES MELLITUS, 2023, 26 (05): : 404 - 417
  • [30] How Would You Manage This Patient With Type 2 Diabetes and Chronic Kidney Disease? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
    Smetana, Gerald W.
    Romeo, Giulio R.
    Rosas, Sylvia E.
    Burns, Risa B.
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (06) : 800 - 811
12345